[
    "{\"step_by_step_thinking\": \"The document [0] provides a detailed study on the use of multipotent adult progenitor cells for the treatment of stroke. The study concludes that the administration of these cells was safe and well tolerated in patients with acute ischaemic stroke. However, no significant improvement was observed at 90 days in neurological outcomes with multipotent adult progenitor cells treatment. Therefore, while the cells can be safely administered, they did not show effectiveness in improving stroke recovery in this study.\", \"answer_choice\": \"B. no\"}"
]